0
0
0
Lower Costs, More Cures Act of 2019
10/28/2022, 1:46 AM
Congressional Summary of HR 19
Lower Costs, More Cures Act of 2019
This bill establishes and modifies several requirements to address prescription drug prices under Medicare, Medicaid, and other programs.
The bill generally
- limits payment amounts for drugs and biologics under Medicare medical services,
- reduces cost-sharing under the Medicare prescription drug benefit,
- modifies certain authorities and requirements under the Medicaid Drug Rebate Program,
- revises provisions relating to regulatory approval and commercial availability of generics and biosimilars, and
- establishes several reporting requirements for drug manufacturers with respect to drug prices.
Read the Full Bill
Current Status of Bill HR 19
Bill HR 19 is currently in the status of Bill Introduced since December 9, 2019. Bill HR 19 was introduced during Congress 116 and was introduced to the House on December 9, 2019. Bill HR 19's most recent activity was Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law. as of December 19, 2019
Bipartisan Support of Bill HR 19
Total Number of Sponsors
1Democrat Sponsors
0Republican Sponsors
1Unaffiliated Sponsors
0Total Number of Cosponsors
147Democrat Cosponsors
0Republican Cosponsors
147Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 19
Primary Policy Focus
HealthPotential Impact Areas
- Administrative law and regulatory procedures
- Administrative remedies
- Advisory bodies
- Appropriations
- Biological and life sciences
- Business records
- Cancer
- Chemistry
- Child health
- Civil actions and liability
- Competition and antitrust
- Congressional oversight
- Consumer affairs
- Corporate finance and management
- Cosmetics and personal care
- Department of Health and Human Services
- Digestive and metabolic diseases
- Drug safety, medical device, and laboratory regulation
- Drug therapy
- Executive agency funding and structure
- Federal Trade Commission (FTC)
- Food and Drug Administration (FDA)
- Fraud offenses and financial crimes
- Genetics
- Government information and archives
- Government studies and investigations
- Health care costs and insurance
- Health information and medical records
- Health personnel
- Health programs administration and funding
- Health technology, devices, supplies
- Home and outpatient care
- Hospital care
- Immunology and vaccination
- Income tax deductions
- Income tax exclusion
- Inflation and prices
- Intellectual property
- Intergovernmental relations
- Judicial review and appeals
- Licensing and registrations
- Manufacturing
- Marketing and advertising
- Medicaid
- Medical education
- Medical research
- Medical tests and diagnostic methods
- Medicare
- Office of the U.S. Trade Representative
- Prescription drugs
- Product development and innovation
- Public participation and lobbying
- Research and development
- Retail and wholesale trades
- State and local government operations
- Trade agreements and negotiations
- User charges and fees
- Women's health
Alternate Title(s) of Bill HR 19
Lower Costs, More Cures Act of 2019
To provide for certain reforms with respect to the Medicare program under title XVIII of the Social Security Act, the Medicaid program under title XIX of such Act, the Food and Drug Administration, and for other purposes.
Lower Costs, More Cures Act of 2019
Over-the-Counter Monograph User Fee Act of 2019
Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019
Comments
Sponsors and Cosponsors of HR 19
Latest Bills
National Defense Authorization Act for Fiscal Year 2026
Bill S 1071December 13, 2025
Enduring Justice for Victims of Trafficking Act
Bill S 2584December 13, 2025
Technical Corrections to the Northwestern New Mexico Rural Water Projects Act, Taos Pueblo Indian Water Rights Settlement Act, and Aamodt Litigation Settlement Act
Bill S 640December 13, 2025
Incentivizing New Ventures and Economic Strength Through Capital Formation Act of 2025
Bill HR 3383December 13, 2025
BOWOW Act of 2025
Bill HR 4638December 13, 2025
Northern Mariana Islands Small Business Access Act
Bill HR 3496December 13, 2025
Wildfire Risk Evaluation Act
Bill HR 3924December 13, 2025
Energy Choice Act
Bill HR 3699December 13, 2025
ESTUARIES Act
Bill HR 3962December 13, 2025
Improving Interagency Coordination for Pipeline Reviews Act
Bill HR 3668December 13, 2025
Lower Costs, More Cures Act of 2019
Bill S 3129October 28, 2022
Encouraging Innovative Benefit Design to Lower Costs for Seniors Act
Bill S 3013October 28, 2022
Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019
Bill S 2740November 1, 2022
To amend the Biologics Price Competition and Innovation Act of 2009 to make improvements with respect to the transition of biological products, and for other purposes.
Bill HR 6155February 8, 2022
GENE Therapy Payment Act
Bill HR 5882February 8, 2022